Natalie Yates-Bolton, a resilient grandmother-of-two, has defied the odds by surviving cancer not once, not twice, but five times. Battling Hodgkin’s lymphoma and breast cancer, the 57-year-old has undergone an astonishing 11 operations, endured 30 rounds of chemotherapy, and faced 55 sessions of radiotherapy. Despite the grueling treatments, Yates-Bolton has emerged victorious, declared cancer-free after six years of arduous medical interventions.
Reflecting on her journey, Yates-Bolton expressed gratitude for the five chances she’s been given, acknowledging the stark reality that not everyone is as fortunate. She emphasized the importance of perspective, highlighting that while some may view her repeated battles with cancer as unfortunate, she sees them as opportunities for successful outcomes that not everyone receives.
Credit for her remarkable recovery is also attributed to the dedicated medical professionals at The Christie hospital in Manchester, who prescribed a new medication called palbociclib (Ibrance), hailed for its efficacy in eradicating cancer cells. With all scans indicating the cancer’s disappearance, Yates-Bolton credits the NHS for providing access to cutting-edge treatments that have significantly contributed to her survival.
Yates-Bolton’s journey with cancer began during her university years, where she was diagnosed with Hodgkin’s lymphoma at the age of 22. Undeterred by her diagnosis, she persisted in pursuing her nursing degree while undergoing rigorous radiotherapy. Over the years, cancer returned three more times, each time met with resilience and determination to overcome the odds.
Now, Yates-Bolton is focused on living life to the fullest, cherishing moments with her husband and daughters while embracing new challenges. A testament to her indomitable spirit, she has completed an impressive array of endurance events, including marathons, ultra-marathons, and triathlons. Last year alone, she conquered the Isle of Wight ultra-marathon and embarked on the Camino de Santiago pilgrimage with her 80-year-old mother.
Her unwavering optimism and zest for life serve as an inspiration to all who know her. Dr. Sacha Howell, her consultant oncologist, commends Yates-Bolton’s resilience and determination, noting her exceptional response to treatment. Prof Peter Johnson, NHS national clinical director for cancer, highlights the transformative impact of innovative therapies like palbociclib, which have empowered patients like Yates-Bolton to defy the odds and embrace life with renewed vigor.